Eman K. A. Abdelall

1.1k total citations
45 papers, 918 citations indexed

About

Eman K. A. Abdelall is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Eman K. A. Abdelall has authored 45 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Organic Chemistry, 24 papers in Pharmacology and 2 papers in Molecular Biology. Recurrent topics in Eman K. A. Abdelall's work include Synthesis and biological activity (41 papers), Inflammatory mediators and NSAID effects (20 papers) and Synthesis and Biological Evaluation (14 papers). Eman K. A. Abdelall is often cited by papers focused on Synthesis and biological activity (41 papers), Inflammatory mediators and NSAID effects (20 papers) and Synthesis and Biological Evaluation (14 papers). Eman K. A. Abdelall collaborates with scholars based in Egypt, Saudi Arabia and Libya. Eman K. A. Abdelall's co-authors include Khaled R.A. Abdellatif, Gehan M. Kamel, Phoebe F. Lamie, Heba A.H. Elshemy, Abdou O. Abdelhamid, Wael A. A. Fadaly, Rania B. Bakr, Manal M. Kandeel, Mohamed A. Abdelgawad and Madlen B. Labib and has published in prestigious journals such as Molecules, RSC Advances and European Journal of Medicinal Chemistry.

In The Last Decade

Eman K. A. Abdelall

42 papers receiving 903 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eman K. A. Abdelall Egypt	20	825	302	130	75	58	45	918
Phoebe F. Lamie Egypt	18	712 0.9×	214 0.7×	201 1.5×	127 1.7×	63 1.1×	33	875
Heba A.H. Elshemy Egypt	16	560 0.7×	175 0.6×	128 1.0×	60 0.8×	44 0.8×	33	677
Madlen B. Labib Egypt	13	445 0.5×	174 0.6×	100 0.8×	62 0.8×	43 0.7×	17	530
Rasha Z. Batran Egypt	16	557 0.7×	148 0.5×	201 1.5×	71 0.9×	57 1.0×	29	736
Kamelia M. Amin Egypt	16	730 0.9×	171 0.6×	222 1.7×	62 0.8×	63 1.1×	30	887
Mostafa M. M. El-Miligy Egypt	13	528 0.6×	101 0.3×	152 1.2×	65 0.9×	48 0.8×	21	652
M. S. Frasinyuk Ukraine	15	444 0.5×	331 1.1×	285 2.2×	19 0.3×	44 0.8×	102	707
Maria Fesatidou Greece	10	444 0.5×	76 0.3×	181 1.4×	62 0.8×	27 0.5×	17	635
A. A. B. HAZZAA Egypt	12	461 0.6×	97 0.3×	137 1.1×	35 0.5×	47 0.8×	29	560
Gülşen Akalın Çiftçi Türkiye	13	499 0.6×	72 0.2×	219 1.7×	60 0.8×	37 0.6×	37	674

Countries citing papers authored by Eman K. A. Abdelall

Since Specialization

Citations

This map shows the geographic impact of Eman K. A. Abdelall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eman K. A. Abdelall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eman K. A. Abdelall more than expected).

Fields of papers citing papers by Eman K. A. Abdelall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eman K. A. Abdelall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eman K. A. Abdelall. The network helps show where Eman K. A. Abdelall may publish in the future.

Co-authorship network of co-authors of Eman K. A. Abdelall

This figure shows the co-authorship network connecting the top 25 collaborators of Eman K. A. Abdelall. A scholar is included among the top collaborators of Eman K. A. Abdelall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eman K. A. Abdelall. Eman K. A. Abdelall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abdelall, Eman K. A., et al.. (2025). Exploring the Anticancer Properties of Quinoxaline‐Based Molecules: A Systematic Review. Chemistry & Biodiversity. 22(11). e01173–e01173. 1 indexed citations

Abdelall, Eman K. A., et al.. (2025). Synthesis of new selective agents with dual anti-inflammatory and SARS-CoV-2 Mpro inhibitory activity: Antipyrine-celecoxib hybrid analogues; COX-2, COVID-19 cytokine storm and replication inhibitory activities.. Bioorganic Chemistry. 160. 108429–108429.

Abdelall, Eman K. A., et al.. (2025). Novel quinoxaline derivatives as promising cytotoxic agents: structure-based design, in silico studies, VEGFR-2 inhibition, and PI3K/AKT/mTOR pathway modulation. Bioorganic Chemistry. 166. 109116–109116.

Abdelall, Eman K. A., et al.. (2025). Molecular docking, ADME study, Cardiovascular biomarkers and gastric safety of new pyrazoles as selective anti-inflammatory agents. Journal of Molecular Structure. 1340. 142338–142338. 1 indexed citations

Abdelall, Eman K. A., et al.. (2024). Development of safe and antioxidant COX-2 inhibitors; Synthesis, molecular docking analysis and biological evaluation of novel pyrrolizine 5-carboxamides. Bioorganic Chemistry. 143. 107098–107098. 2 indexed citations

Abdelall, Eman K. A., et al.. (2022). Trimethoxyphenyl containing compounds: Synthesis, biological evaluation, nitric oxide release, modeling, histochemical and histopathological studies. Bioorganic Chemistry. 124. 105806–105806. 5 indexed citations

Abdellatif, Khaled R.A., et al.. (2022). Novel pyrazole-oxadiazole hybrids possessing methanesulphonyl pharmacophore with good gastric safety profile: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory activity and histopathological studies. Journal of Molecular Structure. 1266. 133529–133529. 3 indexed citations

Abdellatif, Khaled R.A., et al.. (2021). Design, synthesis of new anti-inflammatory agents with a pyrazole core: COX-1/COX-2 inhibition assays, anti-inflammatory, ulcerogenic, histopathological, molecular Modeling, and ADME studies. Journal of Molecular Structure. 1240. 130554–130554. 32 indexed citations

Abdellatif, Khaled R.A., et al.. (2019). New pyrazole derivatives possessing amino/methanesulphonyl pharmacophore with good gastric safety profile: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory activity and histopathological studies. Bioorganic Chemistry. 95. 103540–103540. 38 indexed citations

10.

Abdelall, Eman K. A., et al.. (2019). COX-1/COX-2 inhibition assays and histopathological study of the new designed anti-inflammatory agent with a pyrazolopyrimidine core. Bioorganic Chemistry. 86. 235–253. 37 indexed citations

11.

Abdellatif, Khaled R.A., et al.. (2019). Design, synthesis of celecoxib-tolmetin drug hybrids as selective and potent COX-2 inhibitors. Bioorganic Chemistry. 90. 103029–103029. 19 indexed citations

12.

Elshemy, Heba A.H., et al.. (2016). Synthesis, anti-inflammatory, cyclooxygenases inhibitions assays and histopathological study of poly-substituted 1,3,5-triazines: Confirmation of regiospecific pyrazole cyclization by HMBC. European Journal of Medicinal Chemistry. 127. 10–21. 48 indexed citations

13.

Abdellatif, Khaled R.A., Eman K. A. Abdelall, & Rania B. Bakr. (2016). Nitric Oxide-NASIDS Donor Prodrugs as Hybrid Safe Anti-inflammatory Agents. Current Topics in Medicinal Chemistry. 17(8). 941–955. 40 indexed citations

14.

Abdelall, Eman K. A., et al.. (2014). Enhancement to synthesize, design and dock of novel EGFR inhibitors containing pyrazolo[3,4-d]pyrimidine cores of expectedanticancer activity. 10(12). 5 indexed citations

15.

Abdellatif, Khaled R.A., Eman K. A. Abdelall, Mohamed A. Abdelgawad, Rasha R. Ahmed, & Rania B. Bakr. (2014). Synthesis, docking study and antitumor evaluation of certain newly synthesized pyrazolo[3,4-d]pyrimidine derivatives. 10(4). 10 indexed citations

16.

Kandeel, Manal M., et al.. (2013). Synthesis of Novel Chromenes as Cytotoxic Agents. Journal of Chemical Research. 37(2). 110–114. 5 indexed citations

17.

Abdelall, Eman K. A., et al.. (2012). Synthesis of some novel chromene derivatives. 8(9). 1 indexed citations

18.

Bakr, Rania B., Eman K. A. Abdelall, Mohamed Abdel‐Hamid, & Manal M. Kandeel. (2012). DESIGN AND SYNTHESIS OF NEW EGFR- TYROSINE KINASE INHIBITORS CONTAINING PYRAZOLO[3,4-d]PYRIMIDINE CORES AS ANTICANCER AGENTS. Bulletin of Pharmaceutical Sciences Assiut. 35(1). 27–42. 23 indexed citations

19.

Abdelall, Eman K. A., et al.. (2011). Synthesis of some new of thieno[2,3-b]pyridines, pyrazolo[1,5-a]pyrimidine, [1,2,4]triazolo[1,5-a]pyrimidine, pyrazolo[5,1-c]triazine and pyrimido[1,2-a]benzimidazole derivatives containing pyridine moiety. European Journal of Chemistry. 2(4). 509–513. 3 indexed citations

20.

Abdelhamid, Abdou O., et al.. (2010). Synthesis and Antimicrobial Activity of Some New 5-Arylazothiazole, Pyrazolo[1,5-a] Pyrimidine, [1,2,4]Triazolo[4,3-a]Pyrimidine, and Pyrimido[1,2-a]Benzimidazole Derivatives Containing the Thiazole Moiety. Phosphorus, sulfur, and silicon and the related elements. 185(4). 709–718. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact